Allan S. Wagman - Concepedia

Author

Allan S. Wagman

The University of Texas at Austin

Also Known As

A. S. WAGMAN, A. S. Wagman, A. Wagman, A.S. Wagman, Allan S Wagman, Allan S. Wagman, Allan Wagman, Allan S. Wagman

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

The University of Texas at Austin Novartis (United States)Omron (Japan)University of North Carolina at Chapel Hill

About

Allan S. Wagman is an author at The University of Texas at Austin specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.6K
2	Biochemistry	10	10	1.2K
3	Natural Sciences	9	9	1.2K
4	Engineering	3	3	91
5	Health Sciences	2	2	252

Allan S. Wagman

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Glycogen Synthase Kinase-3 Regulates Mitochondrial Outer Membrane Permeabilization and Apoptosis by Destabilization of MCL-1 Ulrich Maurer, Céline Charvet, Allan S. Wagman, Molecular Cell Mitochondrial FunctionBiochemistryNatural SciencesApoptosisCell Death	2006	866
Selective Glycogen Synthase Kinase 3 Inhibitors Potentiate Insulin Activation of Glucose Transport and Utilization In Vitro and In Vivo David B. Ring, Kirk W. Johnson, Erik J. Henriksen, Diabetes	2003	546
Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer Matthew T. Burger, Sabina Pecchi, Allan S. Wagman, ACS Medicinal Chemistry Letters 2,4-Bismorpholino 6-Heterocyclic PyrimidinesPi3 Kinase InhibitorOrally Bioavailable ClassGliomaPharmaceutical Chemistry	2011	248
Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor Jérôme Ruzzin, Allan S. Wagman, Jørgen Jensen Diabetologia Insulin ResistanceMetabolic SyndromeInsulin SignallingSkeletal MuscleMedicine	2005	239
The Total Synthesis of (±)-Ginkgolide B Michael T. Crimmins, Jennifer M. Pace, Philippe G. Nantermet, Journal of the American Chemical Society Medicinal ChemistryGinkgolide BBioorganic ChemistryHeterocyclicBiochemistry	2000	105
Ring-closing olefin meta thesis for the synthesis of fused nitrogen heterocycles Stephen F. Martin, Hui-Ju Chen, Anne K. Courtney, Tetrahedron HeterocyclicAlkene MetathesisFused Nitrogen HeterocyclesOrganic ChemistryChemistry	1996	103
4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors Zhi‐Jie Ni, Paul A. Barsanti, Nathan Brammeier, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPotent Chk-1 InhibitorsMedicinePharmacological AgentPharmacotherapy	2006	70
A general method for the synthesis of 1,1-difluoroalkylphosphonates Stephen F. Martin, Daniel W. Dean, Allan S. Wagman Tetrahedron Letters Fluorous SynthesisOrganic ChemistryChemistryGeneral MethodSynthesis Method	1992	61
A novel approach to FR-900482 via ring forming metathesis Stephen F. Martin, Allan S. Wagman Tetrahedron Letters Materials ScienceEngineeringAlkene MetathesisNovel ApproachCrystallography	1995	60
Design, Synthesis, and Evaluation of Phospholipid Analogs as Inhibitors of the Bacterial Phospholipase C from Bacillus cereus Stephen F. Martin, Yue-Ling Wong, Allan S. Wagman The Journal of Organic Chemistry Microbial PathogensAntibiotic AdjuvantPhospholipid AnalogsAltmetric Attention ScoreAntimicrobial Chemotherapy	1994	58

Page 1